Emerging MRI methods in rheumatoid arthritis

Nature Reviews Rheumatology

Volumn 7, Issue 2, 2011, Pages 85-95

  Borrero, Camilo G ^a   Mountz, James M ^a   Mountz, John D ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GADOLINIUM; GADOLINIUM PENTETATE; SODIUM 23; TUMOR NECROSIS FACTOR INHIBITOR;

BONE EROSION; BONE MARROW EDEMA; CARTILAGE DEGENERATION; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; EARLY DIAGNOSIS; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYNOVITIS; SYSTEMATIC REVIEW; TREATMENT PLANNING;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE MARROW DISEASES; CARTILAGE; CONTRAST MEDIA; EDEMA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; SYNOVITIS;

EID: 79651468992     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.173     Document Type: Review

References (90)

1. Taylor, P. C. & Feldmann, M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 578-582 (2009).
2. Maini, R. N. et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 54, 2817-2829 (2006). (Pubitemid 44497760)
3. Cohen, S. B. et al. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelvemonth, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 58, 1299-1309 (2008). (Pubitemid 351705919)
4. Lewiecki, e. M. Denosumab update. Curr. Opin. Rheumatol. 21, 369-373 (2009).
5. van den Berg, w. B. & Miossec, P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 549-553 (2009).
6. Kremer, J. M. et al. The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebocontrolled phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis Rheum. 60, 1895-1905 (2009).
7. Dorner, T. & Burmester, G. R. New approaches of B-cell-directed therapy: beyond rituximab. Curr. Opin. Rheumatol. 20, 263-268 (2008). (Pubitemid 351483314)
8. Dorner, T., Radbruch, A. & Burmester, G. R. B-cell-directed therapies for autoimmune disease. Nat. Rev. Rheumatol. 5, 433-441 (2009).
9. eisenberg, R. & Albert, D. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2, 20-27 (2006). (Pubitemid 43153645)
10. Steinberg, J. J., Kincaid, S. B. & Sledge, C. B. Inhibition of cartilage breakdown by hydrocortisone in a tissue culture model of rheumatoid arthritis. Ann. Rheum. Dis. 42, 323-330 (1983). (Pubitemid 13105607)
11. Arner, e. C., Harris, R. R., DiMeo, T. M., Collins, R. C. & Galbraith, w. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. J. Rheumatol. 22, 1338-1346 (1995).
12. Yasuda, T. & Poole, A. R. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum. 46, 138-148 (2002). (Pubitemid 34121660)
13. Yodlowski, M. L. et al. Antibody to interleukin 1 inhibits the cartilage degradative and thymocyte proliferative actions of rheumatoid synovial culture medium. J. Rheumatol. 17, 1600-1607 (1990).
14. elliott, S. & Cawston, T. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders. Drugs Aging 18, 87-99 (2001). (Pubitemid 32269583)
15. Nagase, H. & Kashiwagi, M. Aggrecanases and cartilage matrix degradation. Arthritis Res. Ther. 5, 94-103 (2003). (Pubitemid 36849755)
16. Medicherla, S. et al. A selective p38 alpha mitogen-activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen-induced arthritis. J. Pharmacol. Exp. Ther. 318, 132-141 (2006).
17. Catrina, A. I. et al. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford) 41, 484-489 (2002). (Pubitemid 34567176)
18. Ranganathan, P. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNFblocking agents. Curr. Opin. Mol. Ther. 10, 562-567 (2008).
19. Moran, e. M. et al. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res. Ther. 11, R113 (2009).
20. Rannou, F., Francois, M., Corvol, M. T. & Berenbaum, F. Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine 73, 29-36 (2006). (Pubitemid 43197702)
21. McQueen, F. et al. OMeRACT rheumatoid arthritis magnetic resonance imaging studies. Summary of OMeRACT 6 MR imaging module. J. Rheumatol. 30, 1387-1392 (2003). (Pubitemid 36666374)
22. McQueen, F. M. et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 48, 1814-1827 (2003). (Pubitemid 36828675)
23. Schirmer, C. et al. Diagnostic quality and scoring of synovitis, tenosynovitis and erosions in lowfield MRI of patients with rheumatoid arthritis: a comparison with conventional MRI. Ann. Rheum. Dis. 66, 522-529 (2007). (Pubitemid 46580475)
24. Østergaard, M. et al. OMeRACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMeRACT RA-MRI scoring system. J. Rheumatol. 30, 1385-1386 (2003). (Pubitemid 36666373)
25. Haavardsholm, e. A. et al. Reliability and sensitivity to change of the OMeRACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting. Arthritis Rheum. 52, 3860-3867 (2005). (Pubitemid 41798224)
26. Bird, P. et al. A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis. J. Rheumatol. 34, 854-856 (2007). (Pubitemid 46641397)
27. Conaghan, P. G. et al. A multicenter reliability study of extremity-magnetic resonance imaging in the longitudinal evaluation of rheumatoid arthritis. J. Rheumatol. 34, 857-858 (2007). (Pubitemid 46641398)
28. Klarlund, M. et al. Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. Ann. Rheum. Dis. 59, 521-528 (2000). (Pubitemid 30445830)
29. McQueen, F. M. et al. what is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann. Rheum. Dis. 60, 859-868 (2001). (Pubitemid 32778176)
30. McQueen, F. M. et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann. Rheum. Dis. 58, 156-163 (1999). (Pubitemid 29172571)
31. Jevtic, v. et al. Precontrast and postcontrast (Gd-DTPA) magnetic resonance imaging of hand joints in patients with rheumatoid arthritis. Clin. Radiol. 48, 176-181 (1993). (Pubitemid 23267658)
32. Brennan, P. et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ 313, 471-476 (1996). (Pubitemid 26280356)
33. Sugimoto, H., Takeda, A. & Hyodoh, K. earlystage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Radiology 216, 569-575 (2000). (Pubitemid 30599883)
34. Sommer, O. J. et al. Rheumatoid arthritis: a practical guide to state-of-the-art imaging, image interpretation, and clinical implications. Radiographics 25, 381-398 (2005). (Pubitemid 40547055)
35. Ostendorf, B. et al. Magnetic resonance imaging and miniarthroscopy of metacarpophalangeal joints: Sensitive detection of morphologic changes in rheumatoid arthritis. Arthritis Rheum. 44, 2492-2502 (2001). (Pubitemid 33049327)
36. ejbjerg, B. J., Narvestad, e., Jacobsen, S., Thomsen, H. S. & Østergaard, M. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann. Rheum. Dis. 64, 1280-1287 (2005). (Pubitemid 41206243)
37. Hetland, M. L. et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMeSTRA). Ann. Rheum. Dis. 68, 384-390 (2009).
38. Naraghi, A. M., white, L. M., Patel, C., Tomlinson, G. & Keystone, e. C. Comparison of 1.0-T extremity MR and 1.5-T conventional high-field-strength MR in patients with rheumatoid arthritis. Radiology 251, 829-837 (2009).
39. Tehranzadeh, J., Ashikyan, O. & Dascalos, J. Advanced imaging of early rheumatoid arthritis. Radiol. Clin. North Am. 42, 89-107 (2004). (Pubitemid 38283558)
40. Shabana, w. M. et al. Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am. J. Roentgenol. 190, 736-741 (2008). (Pubitemid 351304519)
41. Marckmann, P. et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J. Am. Soc. Nephrol. 17, 2359-2362 (2006). (Pubitemid 44300951)
42. Ostergaard, M. et al. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection-does it change the assessment of inflammatory and destructive joint changes by the OMeRACT RAMRIS? J. Rheumatol. 36, 1806-1810 (2009).
43. Narváez, J. A., Narváez, J, De Lama, e. & De Albert, M. MR imaging of early rheumatoid arthritis. Radiographics 30, 143-163 (2010).
44. Narváez, J. A., Narváez, J., Roca, Y. & Aguilera, C. MR imaging assessment of clinical problems in rheumatoid arthritis. Eur. Radiol. 12, 1819-1828 (2002). (Pubitemid 36940267)
45. Ostergaard, M. & ejbjerg, B. Magnetic resonance imaging of the synovium in rheumatoid arthritis. Semin. Musculoskelet. Radiol. 8, 287-299 (2004). (Pubitemid 40083114)
46. Rand, T. et al. Discrimination between fluid, synovium, and cartilage in patients with rheumatoid arthritis: contrast enhanced spin echo versus non-contrast-enhanced fatsuppressed gradient echo MR imaging. Clin. Radiol. 54, 107-110 (1999). (Pubitemid 29077913)
47. van der Leij, C., van de Sande, M. G., Lavini, C., Tak, P. P. & Maas, M. Rheumatoid synovial inflammation: pixel-by-pixel dynamic contrastenhanced MR imaging time-intensity curve shape analysis-a feasibility study. Radiology 253, 234-240 (2009).
48. Hodgson, R. et al. Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann. Rheum. Dis. 67, 270-272 (2008). (Pubitemid 351183322)
49. Hodgson, R. J. et al. Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis. Skeletal Radiol. 37, 201-207 (2008).
50. Zierhut, M. L., Gardner, J. C., Spilker, M. e., Sharp, J. T. & vicini, P. Kinetic modeling of contrast-enhanced MRI: an automated technique for assessing inflammation in the rheumatoid arthritis wrist. Ann. Biomed. Eng. 35, 781-795 (2007). (Pubitemid 46626139)
51. Boesen, M. et al. MRI quantification of rheumatoid arthritis: current knowledge and future perspectives. Eur. J. Radiol. 71, 189-196 (2009).
52. Kubassova, O., Boesen, M., Cimmino, M. A. & Bliddal, H. A computer-aided detection system for rheumatoid arthritis MRI data interpretation and quantification of synovial activity. Eur. J. Radiol. 74, e67-e72 (2010).
53. Peloschek, P. et al. Assessement of rheumatic diseases with computational radiology: current status and future potential. Eur. J. Radiol. 71, 211-216 (2009).
54. Ostergaard, M. et al. Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn. Reson. Imaging 16, 743-754 (1998). (Pubitemid 28496571)
55. Cimmino, M. A. et al. Dynamic gadoliniumenhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum. 48, 1207-1213 (2003). (Pubitemid 36554519)
56. Agarwal, v. et al. Diffusion tensor anisotropy magnetic resonance imaging: a new tool to assess synovial inflammation. Rheumatology (Oxford) 48, 378-382 (2009).
57. Dalbeth, N. et al. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann. Rheum. Dis. 68, 279-282 (2009).
58. Hashizume, M., Hayakawa, N. & Mihara, M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford) 47, 1635-1640 (2008).
59. Li, X. et al. Quantitative assessment of bone marrow edema-like lesion and overlying cartilage in knees with osteoarthritis and anterior cruciate ligament tear using MR imaging and spectroscopic imaging at 3 Tesla. J. Magn. Reson. Imaging 28, 453-461 (2008).
60. Mayerhoefer, M. e. et al. Computer-assisted quantitative analysis of bone marrow edema of the knee: initial experience with a new method. AJR Am. J. Roentgenol. 182, 1399-1403 (2004). (Pubitemid 38668838)
61. Brittberg, M. & winalski, C. S. evaluation of cartilage injuries and repair. J. Bone Joint Surg. Am. 85, 58-69 (2003). (Pubitemid 36535046)
62. McQueen, F. M. et al. High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann. Rheum. Dis. 66, 1581-1587 (2007). (Pubitemid 350205444)
63. Bugatti, S. et al. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum. 52, 3448-3459 (2005). (Pubitemid 41612211)
64. Dohn, U. M. et al. Are bone erosions detected by magnetic resonance imaging and ultrasonography true erosions? A comparison with computed tomography in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res. Ther. 8, R110 (2006).
65. Perry, D. et al. Detection of erosions in the rheumatoid hand; a comparative study of multidetector computerized tomography versus magnetic resonance scanning. J. Rheumatol. 32, 256-267 (2005). (Pubitemid 40209123)
66. van Breuseghem, I. Ultrastructural MR imaging techniques of the knee articular cartilage: problems for routine clinical application. Eur. Radiol. 14, 184-192 (2004). (Pubitemid 38181074)
67. Billinghurst, R. C. et al. enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 99, 1534-1545 (1997). (Pubitemid 27163804)
68. Buckwalter, J. A. & Mankin, H. J. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr. Course Lect. 47, 477-486 (1998).
69. Andreas, K. et al. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res. Ther. 10, R9 (2008).
70. Abramson, S. B., Attur, M. & Yazici, Y. Prospects for disease modification in osteoarthritis. Nat. Clin. Pract. Rheumatol. 2, 304-312 (2006). (Pubitemid 43842259)
71. Fragonas, e. et al. Correlation between biochemical composition and magnetic resonance appearance of articular cartilage. Osteoarthritis Cartilage 6, 24-32 (1998). (Pubitemid 28160881)
72. Smith, H. e. et al. Spatial variation in cartilage T2 of the knee. J. Magn. Reson. Imaging 14, 50-55 (2001).
73. Mosher, T. J., Dardzinski, B. J. & Smith, M. B. Human articular cartilage: influence of aging and early symptomatic degeneration on the spatial variation of T2-preliminary findings at 3 T. Radiology 214, 259-266 (2000). (Pubitemid 30019902)
74. Xia, Y., Moody, J. B. & Alhadlaq, H. Orientational dependence of T2 relaxation in articular cartilage: a microscopic MRI (microMRI) study. Magn. Reson. Med. 48, 460-469 (2002). (Pubitemid 34951323)
75. Dardzinski, B. J., Mosher, T. J., Li, S., van Slyke, M. A. & Smith, M. B. Spatial variation of T2 in human articular cartilage. Radiology 205, 546-550 (1997). (Pubitemid 27467340)
76. Potter, K., Butler, J. J., Horton, w. e. & Spencer, R. G. Response of engineered cartilage tissue to biochemical agents as studied by proton magnetic resonance microscopy. Arthritis Rheum. 43, 1580-1590 (2000). (Pubitemid 30452479)
77. Nieminen, M. T. et al. Quantitative MR microscopy of enzymatically degraded articular cartilage. Magn. Reson. Med. 43, 676-681 (2000). (Pubitemid 30244266)
78. Kight, A. C., Dardzinski, B. J., Laor, T. & Graham, T. B. Magnetic resonance imaging evaluation of the effects of juvenile rheumatoid arthritis on distal femoral weight-bearing cartilage. Arthritis Rheum. 50, 901-905 (2004). (Pubitemid 38326191)
79. Bashir, A., Gray, M. L. & Burstein, D. Gd-DTPA2-as a measure of cartilage degradation. Magn. Reson. Med. 36, 665-673 (1996).
80. Bashir, A., Gray, M. L., Boutin, R. D. & Burstein, D. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Radiology 205, 551-558 (1997). (Pubitemid 27467341)
81. Nieminen, M. T. et al. Spatial assessment of articular cartilage proteoglycans with Gd-DTPA-enhanced T1 imaging. Magn. Reson. Med. 48, 640-648 (2002).
82. Sur, S., Mamisch, T. C., Hughes, T. & Kim, Y. J. High resolution fast T1 mapping technique for dGeMRIC. J. Magn. Reson. Imaging 30, 896-900 (2009).
83. Reddy, R. et al. Sodium MRI of human articular cartilage in vivo. Magn. Reson. Med. 39, 697-701 (1998). (Pubitemid 28189140)
84. Koff, M. F. & Potter, H. G. Noncontrast MR techniques and imaging of cartilage. Radiol. Clin. North Am. 47, 495-504 (2009).
85. 1p mapping of human articular cartilage: initial experience. Radiology 229, 269-274 (2003). (Pubitemid 37152135)
86. 1p and T2 mapping of articular cartilage in osteoarthritis of the knee using 3 T MRI. Osteoarthritis Cartilage 15, 789-797 (2007). (Pubitemid 46888159)
87. 1p mapping of knee cartilage in osteoarthritis. Magn. Reson. Med. 54, 929-936 (2005). (Pubitemid 41457065)
88. 1p-relaxation of articular cartilage at 4 T. Magn. Reson. Med. 46, 419-423 (2001). (Pubitemid 32831313)
89. Dohn, U. M. et al. Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography. Arthritis Res. Ther. 10, R25 (2008).
90. Borthakur, A. et al. Quantifying sodium in the human wrist in vivo by using MR imaging. Radiology 224, 598-602 (2002). (Pubitemid 34809147)